### Objective
Provide details about primary and secondary packaging components for drug substance and drug product.

### Component Diagram
<table>
<tr><td><img src="container_closure_system.png" width="425"/></td></tr>
</table>
 
### Description of Components
**Ingredient**: The active ingredient (stelbatalol) or the ingredients that make up the drug substance or product

**Manufactured Item Definition**: Information about the physical packaged medication item, such as a tablet or capsule

**Medicinal Product Definition**: The drug product (Stelbat tablets, 20mg)

**Observation Definition**: Each individual stability test and their acceptance criteria; also used to group tests

**Packaged Product Definition**: Information about the packaging for a drug product or drug substance

**Plan Definition**: Describes the stability study protocol

**Substance Definition**: Chemical or biological details about substance(s) associated with the active ingredient (molecular weight, molecular formula, stereochemistry, protein or nucleic acid subunits) 

### Examples
**CTD section samples** (PDF):
- <a href="https://github.com/HL7/uv-dx-pq/raw/master/input/examples-pdf/3.2.P.7_Container_Closure_System.pdf ">3.2.P.7 Container Closure System</a>
- <a href="https://github.com/HL7/uv-dx-pq/raw/master/input/examples-pdf/3.2.S.6_Container_Closure_System.pdf ">3.2.S.6 Container Closure System</a>

**HTML rendering** of synthetic CTD data:
- <a href="container_rend_p.html">Drug Product Container Closure System</a>
- <a href="container_rend_s.html">Drug Substance Container Closure System</a>

**FHIR XML/JSON** profiles and validated Bundle examples in this guide, see [Artifacts Index: Container Closure System](artifacts.html#container-closure-system)